Abstract: Provided herein are heterocyclic compounds of the general formula (I), th~ir derivatives, analogs, tautomeric forms, stereoisomers, polymorphs, hydrates, solvates, pharmaceutically acceptable salts and compositions, metabolites and prodrugs thereof, wherein R1, R2, R3 R4 and R5 are as described herein: Further described herein in particular are heterocyclic compounds of the formula (I) for treati~g various diseases and disorders by administering in a patient one or more TNF -<1, Thromboxane synthase, 5-LOX, and PDE4 inhibitors. In particular described herein are methods for treating immunological diseases, inflammation, pain disorder, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; ischemic heart disease; atherosclerosis; cancer; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; cachexia; asthma; bone resorption diseases; ischemia reperfusion injury; brain trauma; multiple sclerosis; sepsis; septic shock; toxic shock syndrome; fever, and myalgias due to infection and diseases mediated by HIV-I; HIV-2; HIV-3; cytomegalovirus (CMV); influenza; adenovirus; the herpes viruses (including HSV-I, HSV-2) and herpes zoster viruses in a mammal comprising administering an effective amount of a compound of formula (I).
| Section | Controller | Decision Date |
|---|---|---|
| # | Name | Date |
|---|---|---|
| 1 | 488-CHE-2007 FORM-3 23-09-2009.pdf | 2009-09-23 |
| 1 | 488-CHE-2007_EXAMREPORT.pdf | 2016-07-02 |
| 2 | abs-488.jpg | 2011-09-03 |
| 2 | 488-CHE-2007 AMENDED PAGES OF SPECIFICATION 23-08-2013.pdf | 2013-08-23 |
| 3 | 488-che-2007-form 1.pdf | 2011-09-03 |
| 3 | 488-CHE-2007 AMENDED CLAIMS 23-08-2013.pdf | 2013-08-23 |
| 4 | 488-CHE-2007 FORM-1 23-08-2013.pdf | 2013-08-23 |
| 4 | 488-che-2007-description(provisional).pdf | 2011-09-03 |
| 5 | 488-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 23-08-2013.pdf | 2013-08-23 |
| 5 | 488-che-2005-correspodance others.pdf | 2011-09-03 |
| 6 | 488-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 12-10-2012.pdf | 2012-10-12 |
| 6 | 488-CHE-2007 AMENDED PAGES OF SPECIFICATION 12-10-2012.pdf | 2012-10-12 |
| 7 | 488-CHE-2007 FORM-3 12-10-2012.pdf | 2012-10-12 |
| 7 | 488-CHE-2007 AMENDED CLAIMS 12-10-2012.pdf | 2012-10-12 |
| 8 | 488-CHE-2007 FORM-3 12-10-2012.pdf | 2012-10-12 |
| 8 | 488-CHE-2007 AMENDED CLAIMS 12-10-2012.pdf | 2012-10-12 |
| 9 | 488-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 12-10-2012.pdf | 2012-10-12 |
| 9 | 488-CHE-2007 AMENDED PAGES OF SPECIFICATION 12-10-2012.pdf | 2012-10-12 |
| 10 | 488-che-2005-correspodance others.pdf | 2011-09-03 |
| 10 | 488-CHE-2007 EXAMINATION REPORT REPLY RECEIVED 23-08-2013.pdf | 2013-08-23 |
| 11 | 488-CHE-2007 FORM-1 23-08-2013.pdf | 2013-08-23 |
| 11 | 488-che-2007-description(provisional).pdf | 2011-09-03 |
| 12 | 488-che-2007-form 1.pdf | 2011-09-03 |
| 12 | 488-CHE-2007 AMENDED CLAIMS 23-08-2013.pdf | 2013-08-23 |
| 13 | abs-488.jpg | 2011-09-03 |
| 13 | 488-CHE-2007 AMENDED PAGES OF SPECIFICATION 23-08-2013.pdf | 2013-08-23 |
| 14 | 488-CHE-2007_EXAMREPORT.pdf | 2016-07-02 |
| 14 | 488-CHE-2007 FORM-3 23-09-2009.pdf | 2009-09-23 |